DIN 02557061 — TEPEZZA 500 MG
TEPEZZA is a powder for solution of Teprotumumab marketed by AMGEN CANADA INC. The full Teprotumumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02557061
- Brand name
- TEPEZZA
- Active ingredient
- Teprotumumab
- Strength
- 500 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Insulin-like growth factor-1 receptor (IGF-1R) inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.